The store will not work correctly when cookies are disabled.
2-(3-(4-chlorophenyl)-3-hydroxy-2,3-dihydrobenzo[d]thiazolo[3,2-a]imidazol-2-yl)acetic acid
ID: ALA3276261
Cas Number: 39225-26-8
PubChem CID: 162367
Max Phase: Preclinical
Molecular Formula: C17H13ClN2O3S
Molecular Weight: 360.82
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)CC1Sc2nc3ccccc3n2C1(O)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C17H13ClN2O3S/c18-11-7-5-10(6-8-11)17(23)14(9-15(21)22)24-16-19-12-3-1-2-4-13(12)20(16)17/h1-8,14,23H,9H2,(H,21,22)
Standard InChI Key: JMBHHZBJVMEEAP-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
5.1747 -5.7074 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7345 -5.7540 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.9466 -5.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9224 -6.8042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6959 -7.0801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1962 -6.4280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2784 -7.7814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3986 -7.4902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4613 -7.7678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0440 -8.4682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4427 -9.1814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2630 -9.1897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6766 -8.4886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0131 -6.4501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4406 -5.7536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2575 -5.7757 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0512 -5.0351 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1343 -7.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6734 -6.3602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8601 -6.4226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5067 -7.1596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9726 -7.8351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7843 -7.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0256 -9.8841 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 19 1 0
18 4 1 0
3 1 2 0
3 4 1 0
2 3 1 0
4 5 1 0
5 6 1 0
6 2 1 0
5 7 1 0
5 8 1 0
7 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 7 1 0
6 14 1 0
14 15 1 0
15 16 2 0
15 17 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
11 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 360.82 | Molecular Weight (Monoisotopic): 360.0335 | AlogP: 3.33 | #Rotatable Bonds: 3 |
Polar Surface Area: 75.35 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.21 | CX Basic pKa: 3.56 | CX LogP: 3.73 | CX LogD: 1.05 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.75 | Np Likeness Score: -0.42 |
References
1. Bell SC, Wei PH.. (1976) Syntheses of heterocylic fused thiazole acetic acids. 2., 19 (4): [PMID:1263204] [10.1021/jm00226a016] |